Stout has advised Trialbee AB (“Trialbee”) on its sale to Varsity Healthcare Partners. Stout served as exclusive sell-side financial advisor to Trialbee in connection with the transaction, which closed in December 2025.

Trialbee is a Sweden-headquartered, technology-enabled provider of clinical trial patient recruitment services and software, supporting global pharmaceutical sponsors and contract research organizations across multiple therapeutic areas. With meaningful operations in Europe and the United States, Trialbee delivers multi-country recruitment programs through data-driven digital outreach, site and patient enablement, and software-enabled workflows that improve visibility, predictability, and enrollment performance in complex studies.

Varsity Healthcare Partners is a U.S.-based healthcare private equity firm focused on partnering with high-growth healthcare services and technology businesses. The acquisition of Trialbee expands Varsity’s presence in pharma services and technology.